AR070701A1 - Derivados de fluoroglicosidos aromaticos, medicamentos que comprenden estos compuestos y uso de los mismos para producir un medicamento - Google Patents
Derivados de fluoroglicosidos aromaticos, medicamentos que comprenden estos compuestos y uso de los mismos para producir un medicamentoInfo
- Publication number
- AR070701A1 AR070701A1 ARP090100471A ARP090100471A AR070701A1 AR 070701 A1 AR070701 A1 AR 070701A1 AR P090100471 A ARP090100471 A AR P090100471A AR P090100471 A ARP090100471 A AR P090100471A AR 070701 A1 AR070701 A1 AR 070701A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- compounds
- fluoroglycosids
- medicines
- aromatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/04—Carbocyclic radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Los compuestos pueden ser utilizados para tratamiento y control de trastornos metabolicos, en especial la diabetes. Reivindicacion 1: Un compuesto de la formula (1) en donde Ra, Rb, Rc son, independientemente entre sí, H, -COO-alquilo-(C1-6); R1 y R2 son, cada uno, F o R1 es H y R2 es F; R3 es hidrogeno, F, CI, Br, CF3, OCF3, CN, metilo, etilo, metoxi, etoxi, ciclopropilo, CH2-ciclopropilo; Cyc1 es (2); R4, R5, R6, R7 son, independientemente entre sí, hidrogeno, F, CI, Br, I, OH, CF3, NO2, COOH, COO-alquilo-(C1-6), CO-alquilo-(C1-C4), CONH2, CONH-alquilo-(C1-6), CON-[alquilo-(C1-6)]2, alquilo-(C1-6), alquenilo-(C2-6), alquinilo-(C2-6), O-alquilo-(C1-6), HO-alquileno (C1-6), alquilen-(C1-6)-O-alquilo-(C1-6), en donde uno, más de uno o todos los hidrogenos en los radicales alquilo, alquenilo, alquinilo u O-alquilo pueden estar reemplazados por fluor; SO2-NH2, SO2NH-alquilo-(C1-6), SO2N-[alquilo-(C1-6)]2, S-alquilo(C1-6), SCF3, SO-alquilo-(C1-6), SO2-alquilo-(C1-6), NH2; y sus sales farmacéuticamente compatibles.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08290152 | 2008-02-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR070701A1 true AR070701A1 (es) | 2010-04-28 |
Family
ID=39617750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090100471A AR070701A1 (es) | 2008-02-13 | 2009-02-11 | Derivados de fluoroglicosidos aromaticos, medicamentos que comprenden estos compuestos y uso de los mismos para producir un medicamento |
Country Status (15)
Country | Link |
---|---|
US (1) | US20110059910A1 (es) |
EP (1) | EP2268653A2 (es) |
JP (1) | JP2011511820A (es) |
KR (1) | KR20100121615A (es) |
CN (1) | CN101998962A (es) |
AR (1) | AR070701A1 (es) |
AU (1) | AU2009214278A1 (es) |
BR (1) | BRPI0907572A2 (es) |
CA (1) | CA2714110A1 (es) |
CL (1) | CL2009000309A1 (es) |
IL (1) | IL207201A0 (es) |
MX (1) | MX2010008051A (es) |
TW (1) | TW201000494A (es) |
UY (1) | UY31651A1 (es) |
WO (1) | WO2009100936A2 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2011153712A1 (en) * | 2010-06-12 | 2011-12-15 | Theracos, Inc. | Crystalline form of benzylbenzene sglt2 inhibitor |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
US8614195B2 (en) * | 2011-04-14 | 2013-12-24 | Novartis Ag | Glycoside derivatives and uses thereof |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
US9394329B2 (en) | 2013-09-27 | 2016-07-19 | Sunshine Lake Pharma Co., Ltd. | Glucopyranosyl derivatives and their uses in medicine |
WO2016041470A1 (en) * | 2014-09-15 | 2016-03-24 | National Institute Of Biological Sciences, Beijing | Sglt-2 inhibitors |
WO2018029264A1 (en) | 2016-08-10 | 2018-02-15 | Amneal Pharmaceuticals Company Gmbh | Process for preparation of dapagliflozin and intermediates thereof |
US10696662B2 (en) | 2017-08-21 | 2020-06-30 | Janssen Pharmaceutica Nv | 5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators |
US20210238170A1 (en) | 2018-05-09 | 2021-08-05 | Janssen Pharmaceutica Nv | 5,5-Difluoro- and 5-Fluoro-5-Methyl-C-Glycoside Derivatives Useful As Dual SGLT1 / SGLT2 Modulators |
CN109206331A (zh) * | 2018-09-17 | 2019-01-15 | 康化(上海)新药研发有限公司 | 一种2-甲基丝氨酸的制备方法 |
CN113429379A (zh) * | 2021-06-28 | 2021-09-24 | 江苏法安德医药科技有限公司 | 一种lh-1801中间体及其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10258007B4 (de) * | 2002-12-12 | 2006-02-09 | Sanofi-Aventis Deutschland Gmbh | Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel |
TWI310033B (en) * | 2003-03-14 | 2009-05-21 | Yamanouchi Pharma Co Ltd | C-glycoside derivatives or salts thereof |
SI1651658T2 (sl) * | 2003-08-01 | 2020-12-31 | Mitsubishi Tanabe Pharma Corporation | Nove spojine, ki imajo inhibitorno aktivnost proti transporterju, ki je odvisen od natrija |
DE102004048388A1 (de) * | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | D-Pyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
US20080027014A1 (en) * | 2006-07-28 | 2008-01-31 | Tanabe Seiyaku Co., Ltd. | Novel SGLT inhibitors |
-
2009
- 2009-02-11 TW TW098104261A patent/TW201000494A/zh unknown
- 2009-02-11 UY UY031651A patent/UY31651A1/es not_active Application Discontinuation
- 2009-02-11 AR ARP090100471A patent/AR070701A1/es unknown
- 2009-02-11 CL CL2009000309A patent/CL2009000309A1/es unknown
- 2009-02-13 EP EP09711333A patent/EP2268653A2/de not_active Withdrawn
- 2009-02-13 JP JP2010546266A patent/JP2011511820A/ja not_active Abandoned
- 2009-02-13 CN CN2009801125891A patent/CN101998962A/zh active Pending
- 2009-02-13 BR BRPI0907572-0A patent/BRPI0907572A2/pt not_active IP Right Cessation
- 2009-02-13 WO PCT/EP2009/001042 patent/WO2009100936A2/de active Application Filing
- 2009-02-13 MX MX2010008051A patent/MX2010008051A/es unknown
- 2009-02-13 CA CA2714110A patent/CA2714110A1/en not_active Abandoned
- 2009-02-13 AU AU2009214278A patent/AU2009214278A1/en not_active Abandoned
- 2009-02-13 KR KR1020107017950A patent/KR20100121615A/ko not_active Application Discontinuation
-
2010
- 2010-07-25 IL IL207201A patent/IL207201A0/en unknown
- 2010-08-06 US US12/851,944 patent/US20110059910A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL207201A0 (en) | 2010-12-30 |
TW201000494A (en) | 2010-01-01 |
UY31651A1 (es) | 2009-09-30 |
WO2009100936A2 (de) | 2009-08-20 |
CA2714110A1 (en) | 2009-08-20 |
CL2009000309A1 (es) | 2009-06-26 |
EP2268653A2 (de) | 2011-01-05 |
CN101998962A (zh) | 2011-03-30 |
AU2009214278A1 (en) | 2009-08-20 |
US20110059910A1 (en) | 2011-03-10 |
KR20100121615A (ko) | 2010-11-18 |
WO2009100936A3 (de) | 2009-10-22 |
MX2010008051A (es) | 2010-08-10 |
BRPI0907572A2 (pt) | 2015-07-21 |
JP2011511820A (ja) | 2011-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR070701A1 (es) | Derivados de fluoroglicosidos aromaticos, medicamentos que comprenden estos compuestos y uso de los mismos para producir un medicamento | |
CO5580820A2 (es) | Derivados novedosos de acido (2s)-3-(4-{2-[amino]-2-oxoetoxi} fenil)-2-etoxipropanoico procesos para su preparacion y composiciones farmaceuticas que los contienen | |
CO6351726A2 (es) | Compuestos pirazolicos 436 | |
NI201000085A (es) | Derivados bis - (sulfonilamino) en terapia 066. | |
AR084507A1 (es) | Derivados de indazoliltriazol | |
UY27740A1 (es) | Nuevos compuestos | |
DOP2010000191A (es) | Derivados bis-(sulfonilamino) | |
AR061968A1 (es) | Ester isopropilico del acido 4-[5-metoxi-6-(2-metil-6-[1,2,4]triazol-i-il-piridin-3-il-amino)-pirimidin-4-iloxi]-piperidin-i-carboxilico, composicion farmaceutica que lo comprende y un metodo de preparacion de la misma y el uso de este compuesto para el tratamiento de trastornos metabolicos | |
AR038045A1 (es) | Agentes terapeuticos | |
UY31468A1 (es) | Derivados bis-(sulfonilamino) en terapia 065 | |
UY26727A1 (es) | Derivados de tropano útiles en terapia | |
UY31265A (es) | (2s,3 r)-n-( 2-((3-piridinil)metil)-1-azabiciclo[2.2.2]oct-3-il)benzofuran-2-carboxamida, formas de sales novedosas de ella, y metodos de uso de ella | |
ECSP045483A (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso | |
AR040474A1 (es) | Derivados de tiofenolglicosido, procedimientos para la preparacion de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
UY29818A1 (es) | Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos | |
ECSP099706A (es) | Nuevos derivados de n-(8-heteroariltetrahidronaftalen-2yl) y n-(5-heteroarilcroman-3-il) carboxamida para el tratamiento del dolor | |
UY30048A1 (es) | Derivados sustituidos de la n,2-(1h-benzimidazol-1-il) acetamida, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones | |
AR078278A1 (es) | Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro. | |
UY33037A (es) | Compuestos benzoimidazólicos y sus usos | |
AR060349A1 (es) | Utilizacion de la agomelatina para la obtencion de medicamentos destinados al tratamiento del trastorno de ansiedad generalizada | |
AR040489A1 (es) | Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido, su uso para la elaboracion de medicamentos, un proceso para elaborar los compuestos y medicamentos que los contienen | |
PE20081395A1 (es) | Derivados de aril sulfamida y metodos para su uso | |
CL2011001088A1 (es) | Sal clorhidrato cristalina de 4-[2-(2,4,6-trifluorofenoximetil)fenil]piperidina; composicion farmaceutica que la comprende; y uso para tratar un trastorno doloroso, depresivo, afectivo, cognitivo, obesidad, sindrome de fatiga cronica, incontinencia urinaria por stress. | |
AR043430A1 (es) | Derivados de diarilcicloalquilo, procesos para su preparacion y su uso como agentes farmaceuticos | |
AR064241A1 (es) | Metodos para el tratamiento de la depresion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |